Because of poor compliance, 25% of all patients who are prescribed medicines derive no clinical benefit whatsoever.
Because of poor compliance, 25% of all patients who are prescribed medicines derive no clinical benefit whatsoever. As a result, pharmaceutical companies bear a drastic fall in revenues. AXA Assistance, experts in delivering/ leading providers of patient communication programmes, can share more than 8 years' experience in tailoring and managing successful compliance programmes.
As part of the AXA Global Group and one of the world?s top 20 companies, our service centres operate 24/7/365 out of over 30 sites around the world, offering tailored solutions to the pharmaceutical industry. We have supported many brands and, with an average increase in compliance of 30%, demonstrated a profitable return on investment.
Our core services include:
We believe that we have broken new ground by being the first company that truly meets all objectives of improving patient compliance. The principle aim is for patients and healthcare professionals to reap the benefits in turn deriving the maximum benefit for your brand. AXA Assistance ensure that the following is delivered as a minimum on all programmes implemented:
For further details contact:
Sunita Apte, Pharmaceutical Business Manger
Tel: +44 (0) 870 2406541
sunita.apte@axa-assistance.co.uk
Or visit www.axa-assistance.co.uk
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.